全文获取类型
收费全文 | 5655篇 |
免费 | 355篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 37篇 |
儿科学 | 125篇 |
妇产科学 | 182篇 |
基础医学 | 784篇 |
口腔科学 | 142篇 |
临床医学 | 760篇 |
内科学 | 1197篇 |
皮肤病学 | 84篇 |
神经病学 | 536篇 |
特种医学 | 109篇 |
外科学 | 483篇 |
综合类 | 29篇 |
一般理论 | 3篇 |
预防医学 | 670篇 |
眼科学 | 45篇 |
药学 | 328篇 |
中国医学 | 25篇 |
肿瘤学 | 503篇 |
出版年
2023年 | 45篇 |
2022年 | 77篇 |
2021年 | 175篇 |
2020年 | 97篇 |
2019年 | 148篇 |
2018年 | 141篇 |
2017年 | 120篇 |
2016年 | 128篇 |
2015年 | 158篇 |
2014年 | 197篇 |
2013年 | 301篇 |
2012年 | 428篇 |
2011年 | 496篇 |
2010年 | 240篇 |
2009年 | 228篇 |
2008年 | 384篇 |
2007年 | 368篇 |
2006年 | 369篇 |
2005年 | 336篇 |
2004年 | 349篇 |
2003年 | 324篇 |
2002年 | 282篇 |
2001年 | 33篇 |
2000年 | 31篇 |
1999年 | 48篇 |
1998年 | 53篇 |
1997年 | 49篇 |
1996年 | 27篇 |
1995年 | 30篇 |
1994年 | 28篇 |
1993年 | 28篇 |
1992年 | 18篇 |
1991年 | 24篇 |
1990年 | 15篇 |
1989年 | 14篇 |
1988年 | 20篇 |
1987年 | 17篇 |
1986年 | 18篇 |
1985年 | 9篇 |
1984年 | 27篇 |
1983年 | 18篇 |
1982年 | 19篇 |
1981年 | 18篇 |
1980年 | 17篇 |
1979年 | 7篇 |
1978年 | 10篇 |
1977年 | 9篇 |
1976年 | 7篇 |
1973年 | 13篇 |
1969年 | 5篇 |
排序方式: 共有6042条查询结果,搜索用时 0 毫秒
101.
102.
Ayala Mariana Marchant Margarita Hertz Cristina Castillo Gloria 《International urology and nephrology》2022,54(8):1947-1955
International Urology and Nephrology - The study assessed the impact of intradialytic oral nutritional supplementation on the quality of life in patients receiving hemodialysis and diagnosed with... 相似文献
103.
Josep Antoni Ramos-Quiroga Margarida Corominas-Roso Gloria Palomar Nuria Gomez-Barros Marta Ribases Cristina Sanchez-Mora Rosa Bosch Mariana Nogueira Montserrat Corrales Sergi Valero Miguel Casas 《Psychopharmacology》2014,231(7):1389-1395
Rationale
Atomoxetine (ATX) is a non-stimulant drug approved for the treatment of attention deficit hyperactivity disorder (ADHD). Although animal models have provided evidence that brain-derived neurotrophic factor (BDNF) is involved in the effects of ATX in the brain, there are no studies of BDNF in ADHD patients undergoing treatment with ATX.Objectives
The aim of this study was to evaluate the possible changes in serum levels of BDNF in adults treated with ATX and its relationship with clinical improvement.Methods
A total of 54 adults with ADHD (age 33.43?±?8.99 years) without any medical or psychiatric comorbidities were treated with ATX for 3 months; 35 of them completed the protocol. The clinical data for ADHD diagnosis, including Conners’ ADHD Rating Scale and blood samples, were collected at baseline (V1) and at the end of the treatment (V2).Results
Adults with ADHD who completed ATX treatment for 3 months showed a significant improvement in their clinical symptoms. No significant differences were found in BDNF levels before and after treatment with ATX in the whole group of patients (p?=?0.15). The inattentive subgroup of ATX responders showed a decrease of serum BDNF after 3 months of ATX treatment (p?=?0.05) not present in the combined subtype (p?=?0.82).Conclusions
These results suggest that BDNF is not directly involved in the neurobiological mechanisms of ATX-induced improvement of clinical symptoms of ADHD. The differences between the combined and inattentive subtypes in serum BDNF changes suggest selective ATX-induced effects in the function of brain circuitry. 相似文献104.
105.
106.
Louise L. Dunn Philippa J.L. Simpson Hamish C. Prosser Laura Lecce Gloria S.C. Yuen Andrew Buckle Daniel P. Sieveking Laura Z. Vanags Patrick R. Lim Renee W.Y. Chow Yuen Ting Lam Zoe Clayton Shisan Bao Michael J. Davies Nadina Stadler David S. Celermajer Roland Stocker Christina A. Bursill John P. Cooke Martin K.C. Ng 《Diabetes》2014,63(2):675-687
Impaired angiogenesis in ischemic tissue is a hallmark of diabetes. Thioredoxin-interacting protein (TXNIP) is an exquisitely glucose-sensitive gene that is overexpressed in diabetes. As TXNIP modulates the activity of the key angiogenic cytokine vascular endothelial growth factor (VEGF), we hypothesized that hyperglycemia-induced dysregulation of TXNIP may play a role in the pathogenesis of impaired angiogenesis in diabetes. In the current study, we report that high glucose–mediated overexpression of TXNIP induces a widespread impairment in endothelial cell (EC) function and survival by reducing VEGF production and sensitivity to VEGF action, findings that are rescued by silencing TXNIP with small interfering RNA. High glucose–induced EC dysfunction was recapitulated in normal glucose conditions by overexpressing either TXNIP or a TXNIP C247S mutant unable to bind thioredoxin, suggesting that TXNIP effects are largely independent of thioredoxin activity. In streptozotocin-induced diabetic mice, TXNIP knockdown to nondiabetic levels rescued diabetes-related impairment of angiogenesis, arteriogenesis, blood flow, and functional recovery in an ischemic hindlimb. These findings were associated with in vivo restoration of VEGF production to nondiabetic levels. These data implicate a critical role for TXNIP in diabetes-related impairment of ischemia-mediated angiogenesis and identify TXNIP as a potential therapeutic target for the vascular complications of diabetes. 相似文献
107.
108.
Gabriele Sani Georgios D. Kotzalidis Isabella Panaccione Alessio Simonetti Lavinia De Chiara Antonio Del Casale Elisa Ambrosi Flavia Napoletano Delfina Janiri Emanuela Danese Nicoletta Girardi Chiara Rapinesi Daniele Serata Giovanni Manfredi Alexia E. Koukopoulos Gloria Angeletti Ferdinando Nicoletti Paolo Girardi 《Psychiatry investigation》2014,11(1):95-101
The treatment of premenstrual dysphoric disorder (PMDD) is far from satisfactory, as there is a high proportion of patients who do not respond to conventional treatment. The antidiuretic sulfonamide, acetazolamide, inhibits carbonic anhydrase and potentiates GABAergic transmission; the latter is putatively involved in PMDD. We therefore tried acetazolamide in a series of women with intractable PMDD. Here, we describe a series of eight women diagnosed with DSM-IV-TR PMDD, five of whom had comorbidity with a mood disorder and one with an anxiety disorder, who were resistant to treatment and responded with symptom disappearance after being added-on 125 mg/day acetazolamide for 7-10 days prior to menses each month. Patients were free from premenstrual symptoms at the 12-month follow-up. We suggest that acetazolamide may be used to improve symptoms of PMDD in cases not responding to other treatments. GABAergic mechanisms may be involved in counteracting PMDD symptoms. 相似文献
109.
110.
Sigurdur Y. Kristinsson Gloria Gridley Robert N Hoover David Check Ola Landgren 《Haematologica》2014,99(2):392-398
Although preservation of the spleen following abdominal trauma and spleen-preserving surgical procedures have become gold standards, about 22,000 splenectomies are still conducted annually in the USA. Infections, mostly by encapsulated organisms, are the most well-known complications following splenectomy. Recently, thrombosis and cancer have become recognized as potential adverse outcomes post-splenectomy. Among more than 4 million hospitalized USA veterans, we assessed incidence and mortality due to infections, thromboembolism, and cancer including 8,149 cancer-free veterans who underwent splenectomy with a follow-up of up to 27 years. Relative risk estimates and 95% confidence intervals were calculated using time-dependent Poisson regression methods for cohort data. Splenectomized patients had an increased risk of being hospitalized for pneumonia, meningitis, and septicemia (rate ratios=1.9–3.4); deep venous thrombosis and pulmonary embolism (rate ratios=2.2); certain solid tumors: buccal, esophagus, liver, colon, pancreas, lung, and prostate (rate ratios =1.3–1.9); and hematologic malignancies: non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, acute myeloid leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, and any leukemia (rate ratios =1.8–6.0). They also had an increased risk of death due to pneumonia and septicemia (rate ratios =1.6–3.0); pulmonary embolism and coronary artery disease (rate ratios =1.4–4.5); any cancer: liver, pancreas, and lung cancer, non-Hodgkin lymphoma, Hodgkin lymphoma, and any leukemia (rate ratios =1.3–4.7). Many of the observed risks were increased more than 10 years after splenectomy. Our results underscore the importance of vaccination, surveillance, and thromboprophylaxis after splenectomy. 相似文献